Top 5 Health Care Stocks That Could Blast Off This Month

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30.

Here’s the latest list of major oversold players in this sector, having an RSI near or below 30.

Amgen Inc. (NASDAQ:AMGN)

• US recently approved AstraZeneca and Amgen's Tezspire (tezepelumab) for self-administration in a pre-filled, single-use pen for patients 12 years and older with severe asthma. Amgen also reported fourth-quarter financial results and issued FY23 revenue guidance below estimates. The company’s stock has a 52-week low of $214.39 .
• RSI Value: 27.51
• AMGN Price Action: Shares of Amgen rose 1% to close at $242.50 on Friday.

Zynex, Inc. (NASDAQ:ZYXI)

• Zynex reported preliminary Q4 2022 results, seeing Q4 revenue between $48 million to $51 million. The company’s stock has a 52-week low of $4.97.
• RSI Value: 29.48
• ZYXI Price Action: Shares of Zynex rose 0.1% to close at $12.59 on Friday and lost 1.4% in after-hours trading.

1Life Healthcare, Inc. (NASDAQ:ONEM)

• 1Life Healthcare, during November, posted a Q3 loss of $0.57 per share, versus a year-ago loss of $0.51 per share. The company’s stock has a 52-week low of $5.94.
• RSI Value: 27.60
• ONEM Price Action: Shares of 1Life Healthcare fell 0.9% to close at $15.08 on Friday and lost 0.9% in after-hours trading.

Azenta, Inc. (NASDAQ:AZTA)

• Azenta recently reported worse-than-expected Q1 sales. Stephens also downgraded the stock from Overweight to Equal-Weight. The company’s 52-week low is $37.61.
• RSI Value: 25.47
• AZTA Price Action: Shares of Azenta fell 2.5% to close at $44.80 on Friday.

Globus Medical, Inc. (NYSE:GMED)

• Globus Medical and NuVasive recently agreed to combine in an all-stock transaction, bringing together two technology companies to accelerate globalization strategy to target the $50 billion musculoskeletal market. The company has a 52-week low of $52.60.
• RSI Value: 26.24
• GMED Price Action: Shares of Globus Medical dropped 4.3% to close at $60.28 on Friday.

Read More: $1M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying